In cancer cells, DDR activation was reported to induce Ras/MAPK (236), PI3K/AKT (236), Notch (237), NF-κB (238), PKCα/JAK/Stat (239), and p130CS/JNK pathways (234), thereby participating in various steps of tumor progression (Figure 1). The gene discussed is AKT1; the disease is cancer.